DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction
Public ClinicalTrials.gov record NCT03877237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
International, Multicentre, Parallel-group, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Effect of Dapagliflozin on Exercise Capacity in Heart Failure Patients With Reduced Ejection Fraction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
International, Multicentre, Parallel-group, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the effect of Dapagliflozin on Exercise Capacity in Heart Failure Patients with Reduced Ejection Fraction (HFrEF)
Study identification
- NCT ID
- NCT03877237
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 313 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 150 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2019
- Primary completion
- Mar 6, 2020
- Completion
- Mar 6, 2020
- Last update posted
- May 4, 2021
2019 – 2020
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Alexander City | Alabama | 35010 | — |
| Research Site | Fairhope | Alabama | 36532 | — |
| Research Site | Fort Payne | Alabama | 35967 | — |
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | Torrance | California | 90502 | — |
| Research Site | Stamford | Connecticut | 06905 | — |
| Research Site | Miami | Florida | 33133 | — |
| Research Site | Miami | Florida | 33173 | — |
| Research Site | Tucker | Georgia | 30084 | — |
| Research Site | Munster | Indiana | 46321 | — |
| Research Site | Petoskey | Michigan | 49770 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | New Brunswick | New Jersey | 08901 | — |
| Research Site | Buffalo | New York | 14215 | — |
| Research Site | New York | New York | 10001 | — |
| Research Site | Rosedale | New York | 11422 | — |
| Research Site | Burlington | North Carolina | 27215 | — |
| Research Site | Abington | Pennsylvania | 19001 | — |
| Research Site | Pittsburgh | Pennsylvania | 15212 | — |
| Research Site | Tullahoma | Tennessee | 37388 | — |
| Research Site | Falls Church | Virginia | 22042 | — |
| Research Site | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03877237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2021 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03877237 live on ClinicalTrials.gov.